Forty Seven to Present at Upcoming Investor Conferences in March

MENLO PARK, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) — Forty Seven, Inc. (Nasdaq:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced its participation in the following upcoming investor conferences:
Cowen 40^th Annual Health Care Conference on Tuesday, March 3, 2020 at 8:40 a.m. ET in Boston, MA.32^nd Annual ROTH Conference on Monday, March 16, 2020 at 10:00 a.m. PT (1:00 p.m. ET) in Dana Point, CA.A live webcast of each presentation will be available under “Events & Presentations” in the Investors section of Forty Seven’s website at www.fortyseveninc.com. A replay of the webcasts will be available on Forty Seven’s website for 90 days following each presentation.About Forty Seven, Inc.For more information please visit www.fortyseveninc.com or contact [email protected].For journalist enquiries please contact Sarah Plumridge at [email protected] or phone (312) 506-5218.For investor enquiries please contact Hannah Deresiewicz at Stern Investor Relations Inc. at [email protected] or phone (212) 362-1200.
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow